Cough as Noninvasive Biomarker for Monitoring Tuberculosis Treatment: A Proof-of-Concept Study

Ann Am Thorac Soc. 2023 Dec;20(12):1822-1825. doi: 10.1513/AnnalsATS.202305-456RL.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Biomarkers
  • Cough* / etiology
  • Humans
  • Tuberculosis* / drug therapy

Substances

  • Antitubercular Agents
  • Biomarkers